Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dissecting Aneurysm of the Thoracic Aorta”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01533181
What this trial is testing

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Looking for participantsNCT05498428
What this trial is testing

Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-small-Cell Lung
Janssen Research & Development, LLC 520
Not applicableEnded earlyNCT01147471
What this trial is testing

Flail Chest - Rib Fixation Study

Who this might be right for
Flail Chest
Virginia Commonwealth University 24
Testing effectiveness (Phase 2)Ended earlyNCT02335944
What this trial is testing

Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT01631357
What this trial is testing

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 96
Not applicableUnknownNCT04553601
What this trial is testing

Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer

Who this might be right for
NSCLCPET/CTBiopsy+3 more
The First Affiliated Hospital of Xiamen University 150
Early research (Phase 1)Looking for participantsNCT04842812
What this trial is testing

Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors

Who this might be right for
Liver CancerLung CancerBreast Cancer+5 more
Second Affiliated Hospital of Guangzhou Medical University 40
Early research (Phase 1)Not Yet RecruitingNCT07650357
What this trial is testing

CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerPancreatic Carcinoma+1 more
Clasp Therapeutics, Inc. 140
Early research (Phase 1)Study completedNCT01626001
What this trial is testing

Imaging Study Compare 4DCT Image

Who this might be right for
Esophagus CancerLung Cancer
M.D. Anderson Cancer Center 52
Not applicableUnknownNCT01739881
What this trial is testing

Evaluating the Pulmonary Nodule With Imaging and Biomarkers

Who this might be right for
Lung Cancer
National University Hospital, Singapore 60
Not applicableLooking for participantsNCT06100328
What this trial is testing

Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)

Who this might be right for
Cardiac Tumor
First Affiliated Hospital Xi'an Jiaotong University 40
Testing effectiveness (Phase 2)UnknownNCT05668767
What this trial is testing

Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Beijing Chest Hospital 20
Not applicableStudy completedNCT06651671
What this trial is testing

Tissue Changes Following Thoracic Myofascial Release

Who this might be right for
Myofascial DysfunctionMyofascial Release
Rowan University 60
Testing effectiveness (Phase 2)WithdrawnNCT02662634
What this trial is testing

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
GU Research Network, LLC
Not applicableNot Yet RecruitingNCT07506889
What this trial is testing

Simplified Exercise-based Risk Assessment in Lung Cancer

Who this might be right for
Lung Cancer (Diagnosis)LobectomySurgery Complications+3 more
Linkoeping University 500
Not applicableStudy completedNCT05487313
What this trial is testing

Pain Relief After High Thoracic Eretor Spinae Block

Who this might be right for
Pain, Chronic
Keimyung University Dongsan Medical Center 82
Not applicableWithdrawnNCT06682013
What this trial is testing

Virtual Agent Feasibility in Oncology Patients (NTT Data)

Who this might be right for
Lung Cancer
Duke University
Not applicableStudy completedNCT01140659
What this trial is testing

Objective Evaluation of Patients With Palmar Hyperhidrosis Submitted to Two Levels of Sympathectomy: T3 and T4.

Who this might be right for
HyperhidrosisQuality of Life
University of Sao Paulo 40
Testing effectiveness (Phase 2)Study completedNCT00367679
What this trial is testing

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLung Cancer, Non-Small Cell
GlaxoSmithKline 35
Testing effectiveness (Phase 2)Ended earlyNCT01405846
What this trial is testing

Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib

Who this might be right for
Lung CancerHead and Neck Cancer
Papworth Hospital NHS Foundation Trust 32
Next Page